Can a tablet app ease dialysis symptoms? large trial launches

NCT ID NCT05738330

Recruiting now Symptom relief Sponsor: University of Pennsylvania Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a symptom-monitoring system called SMaRRT-HD helps dialysis patients feel better. About 2,400 adults on hemodialysis at up to 36 U.S. clinics will either use the system or receive usual care. The system lets patients report symptoms on a tablet and alerts clinicians to follow up. The goal is to see if this approach reduces symptom severity and improves quality of life over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SMaRRT-HD symptom monitoring system (behavioral intervention)
What this could lead to: If it works, this could give dialysis patients a simple way to report symptoms and get faster help, reducing discomfort and improving quality of life.
What could go wrong: This is a large but early-stage behavioral study. The system may not significantly reduce symptoms compared to usual care, and results may vary across clinics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

END STAGE KIDNEY DISEASE

Contacts and locations

Locations

Fresenius Medical Care
RECRUITING

Waltham, Massachusetts, 02451, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.